降钙素原
医学
急诊科
败血症
生物标志物
血培养
重症监护医学
内科学
急诊医学
抗生素
生物化学
化学
精神科
微生物学
生物
作者
Dimitrios Velissaris,Nicholas Zareifopoulos,Maria Lagadinou,Chiristina Platanaki,Konstantinos Tsiotsios,E.L. Stavridis,Dimitrios-Ioannis Kasartzian,Charalampos Pierrakos,Vasileios Karamouzos
出处
期刊:PubMed
[National Institutes of Health]
日期:2021-01-01
卷期号:25 (1): 466-479
被引量:43
标识
DOI:10.26355/eurrev_202101_24416
摘要
Procalcitonin elevation may be used as an indication for initiation of antibiotic treatment, and antibiotics may be discontinued once procalcitonin normalizes. This approach leads to reduced antibiotic consumption, but it is not yet clear whether it ensures better outcomes for patients. Procalcitonin in centers where it is available could be a useful diagnostic and prognostic biomarker for patients presenting to the Emergency Department with symptoms suggestive of sepsis. Further research is however required to determine whether the use of procalcitonin measurements in management algorithms leads to improved patient outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI